Why is Oxygenta Pharma falling/rising?

As of 23-Jun, Oxygenta Pharmaceutical Ltd is experiencing a price increase, currently at 122.00, reflecting a rise of 4.5 (3.83%). The stock has shown strong performance today, outperforming its sector by 3.84%, and has gained 7.96% over the last two days. It opened with a 5% gain and reached an intraday high of Rs 123.37. Over the past month, the stock has surged by 34.07%, and it has delivered an impressive 238.89% return over the past year, significantly outperforming the BSE 500 index. However, it is important to note that the company has a negative book value and a weak long-term fundamental strength, with high debt levels and a negative EBITDA, which could pose risks to its valuation despite recent gains.
In the broader market context, Oxygenta's short-term performance has been favorable compared to the benchmark, which has only seen a 0.12% increase over the past week. While the stock has demonstrated exceptional returns in both the short and long term, its high debt and declining profits raise concerns about its sustainability. The stock's liquidity appears adequate for trading, but a significant drop in delivery volume suggests a potential decrease in investor participation, which could impact future price movements. Overall, while the stock is currently rising, the underlying financial challenges may warrant caution among investors.